Takeda Seeks Approval For Moderna's COVID-19 Shot In Japan
March 05, 2021 at 09:27 AM EST
Takeda Pharmaceutical Co Ltd has asked regulators to approve the use of Moderna Inc’s COVID-19 vaccine (mRNA-1273 or TAK-919).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|